Hostname: page-component-cd9895bd7-hc48f Total loading time: 0 Render date: 2024-12-22T06:53:18.739Z Has data issue: false hasContentIssue false
  • English
  • Français

Paroxetine-induced enuresis

Published online by Cambridge University Press:  16 April 2020

Fevziye Toros  and
Kubilay Erdoğan
Fevziye Toros*
Affiliation:
Department of Child and Adolescent Psychiatry, Mersin University School of Medicine, Mersin, Turkey
Kubilay Erdoğan
Affiliation:
Department of Urology, Mersin University School of Medicine, Mersin, Turkey
*
*Corresponding author. Mersin Üniversitesi Tip Fakültesi Psikiyatri AnaBilim Dal1, Zeytinlibahçe cad. 33 079 Mersin, Turkey.

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

I would like to include one case to the literature on children and adolescents who have developed enuresis while taking paroxetine. Up to now, the fact that enuresis may have occurred as a result of the side effect of using paroxetine was not reported in some articles and letters.

Type
Letter to the editor
Information
European Psychiatry , Volume 18 , Issue 1 , February 2003 , pp. 43 - 44
Copyright
Copyright © Éditions scientifiques et médicales Elsevier SAS 2003

References

American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-IV), 4th ed., 1994 Washington (DC).Google Scholar
Hill, J, Meldrum, L, Klarskov, PANovel non-adrenergic, non-cholinergic nerve mediated relaxation of the pig bladder neck: an examination of possible neuro-transmitter candidates. Eur J Pharmacol 1984;99:287.Google Scholar
Hytell, JPharmacological characterization review. Int Clin Psychop-harmacol 1994;4:15–24.Google Scholar
Koff, SAEnuresis. In: Walsh, PC, Retik, AB, Vaughan, ED, Wein, AJ editors. Philadelphia: Campbell’s urology; 1998. p. 2055–88.Google Scholar
Steers, WD. Physiology and pharmacology of the bladder and urethra. In: Walsh, PC, Retik, AB, Vaughan, ED, Wein, AJ editors. Philadelphia: Campbell’s urology; 2003. p. 888.Google Scholar
Nishimura, T, Tokimasa, TAkasu T. 5-Hydroxytryptamine inhibits cholinergic transmission through 5-HT1A receptor subtypes in rabit vesical parasympathetic ganglia. Brain Res 1988;442:399.CrossRefGoogle Scholar
Nishimura, T, Yoshida, M, Nagatsu, I, Akasu, TFrequency dependent inhibition of nicotinic transmission by serotonin in vesical pelvic ganglia of the rabit. Neurosci Lett 1989;103:179.CrossRefGoogle Scholar
Ramaiya, A, Johnson, JH, Karnes, HTEvaluation of the neuropharma-codynamics of paroxetine in vivo utilizing micridialysis. J Pharm Sci 1997;86:1497–500.CrossRefGoogle Scholar
Thomas, DR, Nelson, DR, Johnson, AMBiochemical effects of the antideoressant paroxetine, a spesific 5-hydroxytryptamine uptake inhibitor. Psychopharmacology 1987;93:193–200.CrossRefGoogle Scholar
Ziervogel, CF. Selective serotonin re-uptake inhibitors for children and adolescents. Eur Child Adolescent Psychiatry 2000;9:20–6.CrossRefGoogle ScholarPubMed
Submit a response

Comments

No Comments have been published for this article.